Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes
Abstract
Importance
The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) randomized clinical trial was stopped early owing to the efficacy of low-dose rivaroxaban plus aspirin in preventing major cardiovascular events. The main reason for early trial termination was the effect of combination therapy on reducing ischemic strokes.Objective
To analyze the association between low-dose rivaroxaban with or...Paper Details
Title
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes
Published Date
Jan 1, 2020
Journal
Volume
77
Issue
1
Pages
43 - 43
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History